Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): Its original description and now

by Jacques How, Roger Tabah, Elliot J Mitmaker
Published 2020-01-01

The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature

by Raymon H. Grogan, Elliot J. Mitmaker, Orlo H. Clark
Published 2010-05-01

Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.

by Idit Dotan, Philip J R Roche, Miltiadis Paliouras, Elliot J Mitmaker, Mark A Trifiro
Published 2016-01-01

Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.

by Idit Dotan, Philip J R Roche, Michael Tamilia, Miltiadis Paliouras, Elliot J Mitmaker, Mark A Trifiro
Published 2016-01-01

Prostate-specific membrane antigen–directed nanoparticle targeting for extreme nearfield ablation of prostate cancer cells

by Seung S Lee, Philip JR Roche, Paresa N Giannopoulos, Elliot J Mitmaker, Michael Tamilia, Miltiadis Paliouras, Mark A Trifiro
Published 2017-03-01

Unexpected discrepancies in hospital administrative databases can impact the accuracy of monitoring thyroid surgery outcomes in France.

by Frederic Mercier, Nathalie Laplace, Elliot J Mitmaker, Cyrille Colin, Jean-Louis Kraimps, Frederic Sebag, Stephanie Bourdy, Antoine Duclos, Jean-Christophe Lifante, CATHY Study Group
Published 2018-01-01